1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow nafithromycin: new trials by email Literature Review of nafithromycin trials Research Report on nafithromycin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase II Study of Oral Nafithromycin in CABP Nafithromycin 800 mg 3 days, Nafithromycin 800 mg 5 days, Moxifloxacin 400 mg - Community-Acquired Bacterial Pneumonia (CABP) | Phase 2 | Completed | Wockhardt | 231 | 2016-11-18 | 2019-12-20 |
Wockhardt (1)
United States (1)